Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
186.8 USD | +1.60% |
|
-12.70% | +8.24% |
06-25 | Oppenheimer Downgrades ResMed to Market Perform From Outperform | MT |
06-24 | Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.24% | 27B | |
+4.80% | 212B | |
+10.15% | 188B | |
+30.72% | 157B | |
+33.52% | 114B | |
+3.08% | 64.01B | |
+1.63% | 48.83B | |
-3.39% | 39.3B | |
+1.38% | 35.97B | |
+17.66% | 23.74B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- Transcript : ResMed Inc., Q2 2019 Earnings Call, Jan 24, 2019